Company / Income Tax
Protalix BioTherapeutics, Inc. Income Tax History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$254.0K
FY2025
5-year range
$254.0K / $530.0K
FY2022-FY2025
Trend
-52.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $530,000 to $254,000 over the past 2 years.
Based on SEC 10-K filings.
$254,000 in FY2025 with a 3-year CAGR of -21.7%.
Improved from $530,000 to $254,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -21.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -21.7%, indicating a declining trend.
- In FY2025, income tax decreased 52.1% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $254.0K | -52.1% |
| FY2024 | $530.0K | +0.0% |
| FY2023 | $530.0K | +0.0% |
| FY2022 | $530.0K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026